Syneos Health (SYNH)
(Delayed Data from NSDQ)
$37.58 USD
-0.35 (-0.92%)
Updated Feb 6, 2023 04:00 PM ET
After-Market: $37.59 +0.01 (0.03%) 7:58 PM ET
5-Strong Sell of 5 5
A Value D Growth D Momentum C VGM
Fundamental Charts
About PE Ratio (TTM)
Syneos Health, Inc. has a trailing-twelve-months P/E of 7.63X compared to the Medical Info Systems industry's P/E of 19.64X.
Price to Earnings Ratio or P/E is price / earnings. It is the most commonly used metric for determining a company's value relative to its earnings. In this example, we are using the actual earnings (EPS) for the trailing twelve months (or TTM). A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. In general, a lower number or multiple is usually considered better than a higher one.
SYNH 37.58 -0.35(-0.92%)
Will SYNH be a Portfolio Killer in February?
Zacks Investment Research is releasing its prediction for SYNH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SYNH
Syneos Health (SYNH) Signs New Partnership With Cryoport
Implied Volatility Surging for Syneos Health (SYNH) Stock Options
SYNH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Syneos Health (SYNH) to Launch Serplulimab With New Pact
Syneos Health (SYNH) Hurt by Low Reimbursable Expense, FX Issue
Syneos Health (SYNH) to Enhance Clinical Trials With New Pact
Other News for SYNH
ClearBridge Mid Cap Growth Strategy Q4 2022 Portfolio Manager Commentary
ClearBridge Small Cap Growth Strategy Q4 2022 Portfolio Manager Commentary
ClearBridge Mid Cap Strategy Q4 2022 Portfolio Manager Commentary
ClearBridge Small Cap Value Strategy Q4 2022 Portfolio Manager Commentary
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies